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Abstract. An altered distribution of membrane gangliosides (GM), including GM1, has recently been reported in the brains of
Alzheimer’s disease (AD) patients. Moreover, amyloid-positive synaptosomes obtained from AD brains were found to contain
high-density GM1 clusters, suggesting a pathological significance of GM1 increase at presynaptic neuritic terminals in AD.
Here, we show that membrane GM1 specifically recruits small soluble oligomers of the 42-residue form of amyloid- peptide
(A42), with intracellular flux of Ca2+ ions in primary rat hippocampal neurons and in human neuroblastoma cells. Specific
membrane proteins appear to be involved in the early and transient influx of Ca2+ ions induced by A42 oligomers with high
solvent-exposed hydrophobicity (A+), but not in the sustained late influx of the same oligomers and in that induced by A42
oligomers with low solvent-exposed hydrophobicity (A−) in GM1-enriched cells. In addition, A+ oligomers accumulate in
proximity of membrane NMDA and AMPA receptors, inducing the early and transient Ca2+ influx, although FRET shows
that the interaction is not direct. These results suggest that age-dependent clustering of GM1 within neuronal membranes
could induce neurodegeneration in elderly people as a consequence of an increased ability of the lipid bilayers to recruit
membrane-permeabilizing oligomers. We also show that both lipid and protein components of the plasma membrane can
contribute to neuronal dysfunction, thus expanding the molecular targets for therapeutic intervention in AD.
Keywords: Alzheimer’s disease, AMPA, calcium dysregulation, glutamatergic receptors, GM1, lipid rafts, membrane
permeabilization, NMDA
INTRODUCTION
The monosialotetrahexosylganglioside GM1,
together with cholesterol and sphingomyelin, is
abundant in neuronal membranes (5–10% of the
lipid content in the outer membrane leaflet) and accu-
mulates in liquid-ordered microdomains called lipid
rafts [1]. Alterations in membrane lipid distribution
associated with an age-dependent local increase in
ganglioside density and loss of cholesterol have been
reported in the brain of Alzheimer’s disease (AD)
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patients, and high-density GM1 clustering at presy-
naptic neuritic terminals has been shown to be a
critical step in the aggregation process of amyloid-
peptide (A) [2, 3]. In addition, we have recently
shown the ability of GM1 to recruit oligomers grown
from the 42-residue form of the amyloid- peptide
(A42) to lipid raft domains of the cell membrane
[4]. These data add to, and complement, those
previously reported showing the key importance of
GM1 and its clusters in the neuronal membrane, not
only as promoters of A aggregation [5, 6], but also
as binding sites of A oligomers [7, 8].
Soluble A oligomers are largely considered as the
main toxic species of A and their presence correlates
better than plaque load with cognitive impairment
and neuronal dysfunction in AD patients [9–11].
ISSN 1387-2877/17/$35.00 © 2017 – IOS Press and the authors. All rights reserved
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Several investigators have shown that such species
can be extracted from affected brain tissue using
saline buffers without detergents [12, 13]. Oligomer
cytotoxicity appears to result from the aberrant
interactions of such species with the lipid bilayers,
disrupting cell membranes and impairing their abil-
ity to maintain cellular homeostasis [14–18]. Several
studies support the notion that membrane disruption
induced by A allows the entry of small molecules
and ions, mainly free Ca2+ ions [19–22]. In particu-
lar, it was reported that A can induce a generalized
thinning of the phospholipid bilayer, thereby result-
ing in perturbation of Ca2+ fluxes [23]. The formation
of stable pores and ion channels, usually defined
“annular protofibrils”, in the cell membrane has
also been proposed for amyloid-induced toxicity, in
analogy to prokaryotic pore-forming toxins [24–26],
although more recent data have not supported this
hypothesis. Finally, a mechanism of A oligomer
interaction with cell membranes involving specific
binding to endogenous calcium-permeable channels
has also been suggested [18]. Overall, although the
precise molecular mechanisms of A toxicity remain
unclear, dysregulation of Ca2+ homeostasis is widely
accepted as a key factor [27–29].
In the light of the marked toxicity of A oligomers
to glutamatergic synapses [9, 30–32], one particularly
attractive candidate mechanism contributing to Ca2+
dysregulation in AD is via N-methyl D-aspartate
receptors (NMDA-R) and the relative down-
stream signaling cascades [13, 33]. A oligomers
have been shown to bind to either postsynaptic
NMDA-R [34] and -amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPA-R) [35],
resulting in inhibition of long-term potentiation
(LTP) and synaptic activity. Nevertheless, the
data showing a physical interaction between A
oligomers and glutamatergic receptors is still con-
troversial. In the present study, we investigated the
effects of GM1 abundance on the ability of solu-
ble A oligomers to associate with NMDA-R and
AMPA-R, thus triggering a calcium influx into neu-
ronal cells. In particular, to mimic the ganglioside
density observed in the brains of aged people and
of AD patients, the membrane content of GM1 was
increased threefold in cells exposed to diffusible
A42 oligomers. Our analysis shows that different
types of oligomers can induce Ca2+ dyshomeostasis
in GM1-abundant cells by both channel-independent
and channel-dependent mechanisms, with NMDA-R
and AMPA-R triggering a prompt and transient Ca2+
influx.
MATERIALS AND METHODS
Cell culture
Human neuroblastoma SH-SY5Y cells (A.T.C.C.
Manassas, VA) were cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM), F-12 Ham with 25 mM
HEPES and NaHCO3 (1:1) supplemented with 10%
fetal bovine serum (FBS), 1.0 mM glutamine and
1.0% penicillin and streptomycin solution. Cells were
maintained in a 5.0% CO2 humidified atmosphere at
37◦C and grown until 80% confluence for a maximum
of 20 passages. SH-SY5Y cells were differentiated
for six days with 10M all-trans retinoic acid (RA)
in their medium supplemented with 1% FBS that was
renewed every two days [36]. Cell differentiation was
assessed by SDS-PAGE and western blot analysis
of the expression level of growth-associated protein
GAP43, as previously reported [36]. The enrichment
of the GM1 content was obtained by supplement-
ing neuronal cells with 100g/ml GM1 from bovine
brain (Sigma Aldrich, Saint Louis, MO, USA) for
48 h at 37◦C, as previously described [4]. Accord-
ing to previous evidence in AD brains [37], the
GM1 content in neuronal membranes was increased
by a factor of ca. 3, as assessed by flow cytomet-
ric analysis in conjunction with the cholera toxin
subunit B (CTX-B) conjugate [4]. Cholesterol was
depleted by supplementing the culture medium with
-cyclodextrin (-CD) at 2.0 mM for 30 min at 37◦C
in serum-free medium [15].
Primary hippocampal neurons were obtained
from embryonic day (ED)-17 Sprague-Dawley rats
(Harlan) as described in Bongers et al. [38]. The
experimental procedures were in accordance with
the standards set forth in the Guide for the Care
and Use of Laboratory Animals (published by the
National Academy of Science, National Academy
Press, Washington, D.C.). Hippocampal neurons
were maintained in neuronal basal medium (NBM) at
37◦C in a 5.0% CO2-humidified atmosphere and ana-
lyzed 14 days after plating, as previously described
[39]. GM1 enrichment was obtained by supplement-
ing neurons with GM1 from bovine brain (150g/ml)
for 24 h at 37◦C, as previously described [40].
Preparation of Aβ42 and HypF-N oligomers
The lyophilized A42 peptide (Sigma Aldrich)
was dissolved in 100% hexafluoro-2-isopropanol
(HFIP) at 1.0 mM. Then, aliquots of peptide solu-
tions were dried under nitrogen and stored at –80◦C.
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A+ and A− oligomers were prepared as described
previously [4, 41]. A-derived diffusible ligands
(ADDLs) oligomers were prepared according to the
Lambert’s protocol [42]. HypF-N protein was puri-
fied and converted into toxic (type A) or nontoxic
(type B) aggregates as previously described [43].
The oligomeric status of A42 peptide and HypF-
N protein was determined by tapping mode AFM, as
previously reported [43, 44]. Each type of oligomer
was immediately diluted in the appropriate medium
at a monomer equivalent concentration of 12M
and then added to the cell culture media or to
calcein-loaded small unilamellar vesicles (SUV). For
fluorimetric analysis of oligomer interaction with
cells Fluorescein-labeled A+ (A+FAM) oligomers
were prepared from A42 amine-reactive succin-
imidyl esters of carboxyfluorescein (A42FAM,
AnaSpec, San Jose, CA, USA).
Dot-blot analysis
Dot-blot analyses of A+ and A− A42 oligomers
or HypF-N type A and type B oligomers were per-
formed by spotting 2.0l (0.1 mg/ml for A42 and
0.5 mg/ml for HypF-N) of each conformer onto a
polyvinylidene fluoride (PVDF) membrane. After
overnight blocking (1.0% bovine serum albumin in
TBS/TWEEN 0.1%) the blots were probed with
1:1000 rabbit anti-oligomer (A11) polyclonal anti-
bodies (Thermo Fisher Scientific, Waltham, MA,
USA) and mouse anti-A42 antibodies 6E10 (Signet,
Dedham, MA, USA) or rabbit polyclonal anti-HypF-
N antibodies (Primm S.r.l., Milan, Italy), respectively.
Then, the blots were incubated with 1:5000 diluted
HRP-conjugated anti-rabbit or anti-mouse secondary
antibodies. The immunolabeled bands were detected
using a SuperSignalWest Dura (Pierce, Rockford, IL,
USA).
MTT reduction test
Aggregate cytotoxicity was assessed in SH-SY5Y
cells seeded in 96-well plates by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay, as previously reported [4].
The cells with basal or increased GM1 con-
tent (100g/ml) were treated for 24 h with A42
oligomers (A+, A− or ADDLs, 12M, monomer
equivalents), or with HypF-N type A or type B
oligomers (12M, monomer equivalents). In another
set of experiments the cells with basal or depleted
cholesterol content (-CD) were treated for 24 h
with A42 oligomers (A+, A− or ADDLs, 12M,
monomer equivalents). Cell viability was expressed
as the percentage of MTT reduction in treated cells
as compared to untreated cells.
Preparation of small unilamellar vesicles
and permeability measurement
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC)
was purchased from Avanti Polar Lipids (Alabaster,
AL, USA). DOPC and GM1 were dissolved into
chloroform or methanol/chloroform (1:2 v/v), respec-
tively. Then the solutions were mixed by adding to
DOPC an increasing content of GM1 (0, 10, 20, or
30%). Then, the organic solvents were dried under
a gentle nitrogen stream at room temperature and
completely removed from the lipid film by a vacuum
pump. The film was hydrated with ultrapure water.
For calcein release assay, the dry lipid film resulting
from evaporation was resuspended in 60 mM cal-
cein (Sigma), 1.0 M Tris-HCl buffer, pH 7.5, at a
1.0 mg/ml final lipid concentration. The resuspended
samples were incubated for 1 h at room temperature
to allow lipid hydration and vesicle formation, vor-
texing occasionally. After 1 h, the lipid suspensions
were vigorously vortexed to allow complete detach-
ment of hydrated lipids. The resulting suspension was
subjected to five freeze-thaw cycles of 2 min each:
freezing in liquid nitrogen followed by 2 min thawing
at 37◦C. Then, the sample was sonicated for 20 min at
20 kHz in ice to obtain a clear suspension of SUVs.
The large lipid aggregates and titanium impurities
coming from the sonicator probe were removed by
centrifuging the preparation for 10 min at 10,000× g.
For calcein release assay, the non-encapsulated fluo-
rescent probe was removed by gel-filtration using a
Sephadex G-50 column (1.5 × 7.5 cm).
Fluorescence anisotropy (r) of 1,6-diphenyl-1,3,5-
hexatriene (DPH, Sigma Aldrich) was used to
measure the structural order of SUVs, using a
Perkin-Elmer LS 55 luminescence spectrometer, as
previously reported [44]. SUVs containing DOPC
and different GM1 contents were incubated for
30 min with 12M (monomer equivalents) A42
oligomers (A+ or A–) and then for 30 min with
DPH in a 1:250 probe-to-SUV ratio. DPH fluores-
cent anisotropy was expressed as the percentage of
the value measured in SUVs containing 0% GM1 in
the absence of oligomers.
The alteration of SUV permeability was measured
by the calcein release assay using the luminescence
spectrometer described above. Calcein-loaded SUVs
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were incubated for 30 min with 12M (monomer
equivalents) A42 oligomers (A+ or A–).
Measurements of membrane permeability
SH-SY5Y cells with basal or increased GM1 con-
tent (100g/ml), were cultured on glass coverslips,
loaded with 1.0M calcein-AM (Thermo Fisher Sci-
entific, Waltham, MA, USA) for 10 min at 37◦C
and then treated for 60 min with 12M (monomer
equivalents) A42 oligomers (A+, A– or ADDLs).
After fixation in 2.0% buffered paraformaldehyde
for 10 min, fluorescence emission was detected after
excitation at 488 nm by a TCS SP5 scanning con-
focal microscopy system equipped with an argon
laser source (Leica, Mannheim, Germany), as previ-
ously described [4]. A series of 1.0m thick optical
sections (1024 × 1024 pixels) was taken through
the cell depth for each sample using a Leica Plan
Apo 63× oil immersion objective and projected
as a single composite image by superimposition
(Leica).
Oligomer interaction with human neuroblastoma
cells
SH-SY5Y cells with increased GM1 content
(100g/ml), were incubated 3 h on ice with A+FAM
oligomers (1.0M, monomer equivalent) in the
absence or in the presence of 10 × molar equiva-
lents of unlabeled A+ or A– oligomers of A42,
or type A oligomers of HypF-N. Then, the solu-
tions were removed and the cells washed twice with
cold PBS and subsequently lysed in RIPA buffer
[50 mM Tris–HCl (pH 7.5)/150 mM NaCl/0.1%
(w/v) SDS/1% (v/v) Triton X-100/0.5% (w/v) sodium
deoxycholate] in the presence of a protease inhibitor
cocktail (Sigma Aldrich) and subjected to two cycles
of freeze/thawing (–80◦C/37◦C). The cell lysate fluo-
rescence was measured at Exc/Em 492/518 nm using
the luminescence spectrometer described above. Flu-
orescence intensity values were normalized to total
protein content in the samples, as measured by the
Bradford method [45]. The interaction of A+FAM
oligomers with cells, following 3 h on ice, was also
monitored by confocal microscopy by counterstain-
ing the cell membrane with 5.0g/ml Alexa Fluor
633-conjugated wheat germ agglutinin. Fluores-
cence emission was detected after double excitation
at 488 nm and 633 nm by confocal microscopy
described above.
Cytosolic free Ca2+ levels
SH-SY5Y cells with basal or increased GM1 con-
tent (100g/ml) were treated for 60 min with 12M
(monomer equivalents) A42 oligomers (A+, A–
or ADDLs) or with 12M (monomer equivalents)
HypF-N oligomers (type A or type B). In a set of
competition experiments, the cells with basal GM1
content were pre-treated for 60 min with A– or with
type B oligomers (12M, monomer equivalents) or
for 20 min with the cholera toxin subunit B (CTX-B)
and after washing twice treated for 60 min with A+
oligomers (12M, monomer equivalents). In a sepa-
rate set of experiments, the cells with increased GM1
content (100g/ml) were pre-treated for 10 min on
ice with 0.05% trypsin and after washing twice treated
for 10 or 60 min at 37◦C with A+ or A– oligomers
(12M, monomer equivalents). In another set of
experiments the cells with increased GM1 content
(100g/ml) were pre-treated for 60 min with 5.0M
CNQX, a competitive antagonist of AMPA-R or with
10M memantine (mem), a low-affinity antagonist
of NMDA-R or with 10M cadmium ions (Cd2+),
a competitive blocker of voltage-dependent calcium
channels (VDCCs) (Sigma Aldrich) or with 1:200
diluted rabbit polyclonal anti-AMPA (Merk Milli-
pore, Darmstadt, Germany) or with 1:200 diluted
rabbit polyclonal anti-NMDA (Thermo Fisher Scien-
tific, Waltham, MA, USA) antibodies, as previously
reported [33, 46, 47]. Then, the cells were treated
for 10 min with 12M (monomer equivalents) A42
oligomers (A+ or A–) or with HypF-N oligomers
(type A or type B). The cells with increased GM1
content (100g/ml) were also pre-treated for 60 min
with 5.0M CNQX or with 10M mem, and then
treated for different lengths of time (0, 5, 10, 12, 15,
30, 60, or 180 min) with HypF-N oligomers (type A
or type B, 12M, monomer equivalents).
Primary rat hippocampal neurons with increased
GM1 content (150g/ml) were treated for 60 min
with 12M (monomer equivalents) A42 oligomers
(A+ or A–) in the absence or in the presence of
pre-treatment for 20 min with CTX-B, as previously
reported [40].
The cytosolic Ca2+ was measured by confocal
microscopy in SH-SY5Y cells and in primary neu-
rons loaded with 4.0M Fluo3-AM (Thermo Fisher
Scientific), as previously described [4]. Fluorescence
emission was detected after excitation at 488 nm by
confocal microscopy described above. 10–22 cells,
in three different experiments, were analyzed using
ImageJ software [48]. The fluorescence intensities
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were expressed as the percentage of that measured
in 1.0M ionomycin-treated cells [49].
Oligomer co-localization with calcium channels
Human neuroblastoma SH-SY5Y cells with basal
or increased GM1 content (100g/ml) and pri-
mary rat hippocampal neurons with basal GM1
content seeded on glass coverslips were treated for
20 min with A42 oligomers (A+ or A–,12M,
monomer equivalents). After fixation in 2.0%
buffered paraformaldehyde for 10 min, oligomers
co-localization with AMPA-R and NMDA-R was
monitored by immunostaining. This was done by
incubating the samples first with 1:800 diluted rabbit
polyclonal anti-AMPA (Merk Millipore, Darm-
stadt, Germany), or anti-NMDA, antibodies (Thermo
Fisher Scientific) and 1:800 diluted mouse mono-
clonal anti-A42 antibodies (Signet, Dedham, MA,
USA) for 60 min at 37◦C, and then with 1:1000
diluted Alexa Fluor 594- and 488- conjugated anti-
rabbit or anti-mouse secondary antibodies (Thermo
Fisher Scientific) for 90 min at 37◦C. Fluorescence
emission was detected after double excitation at 594
and 488 nm by confocal microscopy as described
above. Oligomers co-localization with AMPA-R or
NMDA-R was estimated for regions of interest in
10–22 cells using the ImageJ (NIH, Bethesda, MD,
USA) and JACOP plugin (http://rsb.info.nih.gov)
softwares [48].
FRET analysis
The molecular interaction of A+ or A– oligomers
(12M, monomer equivalents) with AMPA-R or
NMDA-R was also analyzed in human neurob-
lastoma SH-SY5Y seeded on glass coverslips by
Fluorescence Resonance Energy Transfer (FRET)
analysis. The cells were exposed to the oligomers for
20 min and then fixed in 2.0% buffered paraformalde-
hyde for 10 min at room temperature. After washing,
the cells were counterstained with 1:800 diluted rab-
bit polyclonal anti-AMPA-R or with 1:800 diluted
rabbit polyclonal anti-NMDA-R antibodies and with
1:800 diluted mouse monoclonal anti-A42 anti-
bodies (Signet, Dedham, MA, USA) for 60 min at
37◦C. Then, the samples were incubated with 1:1000
diluted Alexa-Fluor-546-conjugated anti-rabbit and
Alexa-Fluor-488-conjugated anti-mouse secondary
antibodies, respectively (Thermo Fisher Scientific),
for 90 min at 37◦C. An acceptor bleaching protocol
was used to measure FRET efficiency, as previously
described [50]. Acceptor bleaching was accom-
plished using the TCS SP5 confocal system described
above using the implemented FRET acceptor photo-
bleaching wizard. Pre-bleach and post-bleach images
were serially recorded at 488 nm (donor) and 546 nm
(acceptor), respectively, using an argon laser and
appropriate emission bands. Low laser intensities
were used to avoid acquisition bleaching. The accep-
tor was bleached at high intensity at 546 nm. FRET
efficiency is displayed in pseudo color for better visu-
alization.
Statistical analysis
All data were expressed as means ± standard devi-
ations (SD). Comparisons between the different
groups were performed by ANOVA followed by
Bonferroni’s post comparison test.
RESULTS
Harmless Aβ42 oligomers become toxic in
GM1-enriched neuronal cells
A42 oligomers display a high degree of poly-
morphism, and several different conformers with
differing cytotoxic properties have been described in
the past [13, 51]. Amongst them, two types of small
soluble A42 oligomers have been recently shown
to possess similar size, similarly unfolded secondary
structure, but distinct toxic properties, as a conse-
quence of their structural differences [41, 52]. We
prepared in vitro these alternative conformers of A42
oligomers (named A+ and A–) using different con-
ditions of aggregation according to the protocol of
Ladiwala et al. [41]. The different cross-reaction of
A+ and A– oligomers with the conformation-specific
A11 antibody [53], assessed by immunoblot analy-
sis of the proper amount of oligomers (Fig. 1A), was
in agreement with previous data [41]. The different
behavior of A– oligomers (non-toxic) with respect
to A+ oligomers (toxic) was confirmed in human
SH-SY5Y neuroblastoma cells by using the MTT
assay (Fig. 1B), taking into account some concerns
regarding a nonspecific interference of A peptide
with MTT reduction [54]. However, A– oligomers
become significantly toxic in cells enriched in GM1
content by a factor of ca. 3, where the MTT reduc-
tion assay showed a level of cell impairment similar to
that found in the presence of A+ oligomers (ca. 30%)
(Fig. 1B). A-derived diffusible ligands (ADDLs)
were used as a positive control (Fig. 1B), due to
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Fig. 1. Cytotoxicity of A42 oligomers on human neuroblastoma SH-SY5Y cells with basal and increased GM1 content. A) Dot-blot anal-
ysis of A+ and A– oligomers of A42 probed with conformation-specific (A11, prefibrillar oligomers, top) and sequence-specific (6E10,
N-terminus of A, bottom) antibodies. B) MTT reduction of basal, GM1-enriched (GM1), and cholesterol-depleted (-CD) SH-SY5Y
cells treated for 24 h with A+, A–, and ADDLs oligomers (12M, monomer equivalents). Data are expressed as mean ± SD (n= 4 per
group). The triple (***) asterisk refers to p values lower than 0.001 relative to untreated cells. C) DPH fluorescence anisotropy mea-
sured by incubating SUVs containing different percentages of GM1 with A+ and A– oligomers (12M, monomer equivalents) for 30
min. The single (*) asterisk refers to p values lower than 0.05 relative to SUV containing 0% GM1 and without oligomers. D) Cal-
cein release in SUVs containing different percentages of GM1 incubated with A+ and A– oligomers (12M, monomer equivalents)
for 30 min. Data are expressed as mean ± SD (n= 4 per group). E) Representative confocal scanning microscopy images of basal and
GM1-enriched (GM1) SH-SY5Y cells showing levels of intracellular calcein (green fluorescence) following exposure for 60 min to A+,
A– oligomers, and ADDLs (12M, monomer equivalents). F) Representative confocal scanning microscopy image of GM1-enriched
SH-SY5Y cells treated for 3 h with labelled A+ FAM oligomers (1M, monomer equivalents). Red and green fluorescences indi-
cate the cell membranes and the A42 oligomers, respectively. The histogram shows the fluorescence intensity of A+FAM oligomers
associated with cells treated with A+FAM oligomers (1M, monomer equivalents), in the absence or in the presence of 10 × molar
excess of unlabeled A– or A+ oligomers (10M, monomer equivalents) for 3 h at 4◦C. The fluorescence associated with the cells
was normalized by total protein content. The triple (***) asterisk refers to p values lower than 0.001 relative to cells treated with
A+FAM only.
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their pathological relevance [55]. A similar toxic
effect of soluble oligomers was also observed in cells
depleted of membrane cholesterol by incubating the
cells in solutions containing -cyclodextrin (-CD)
(Fig. 1B). These results suggest that the cholesterol
content of the cell membrane is inversely corre-
lated with the membrane perturbing effects of A42
oligomers. These data are also consistent with our
previous reports showing that disruption of choles-
terol homeostasis can be detrimental to neuronal
cells, because toxic A aggregates interact more
easily with cholesterol-poor membranes [4, 44]. In
addition, these results indicate that A– oligomers
can contribute to the pathogenic process. Thus, none
of the protein misfolded oligomers can be consid-
ered entirely harmless, but an ensemble of different
oligomers is able to interfere with variable efficien-
cies with neuronal viability in elderly people.
Oligomer recruitment to lipid bilayers is higher
both in SUVs and in neuronal cells when
enriched in GM1
The GM1 content in neuronal membranes has
been found to increase both with age [2] and in
the brains of AD patients [3, 37], as compared to
healthy controls. Therefore, an approach mimicking
the GM1 density observed in aged brains appears to
be useful to investigate whether a quantitative rela-
tionship does exist between ganglioside abundance
and oligomers binding to neuronal cells. We have
recently shown that GM1 is able to recruit A42
oligomers to lipid raft domains of the cell membrane
[4]. To further study whether GM1 abundance could
affect the binding capacity of A42 oligomers to the
lipid bilayers, we used small unilamellar vesicles
(SUVs) with a variable content of 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) (70–100%) and
GM1 (0–30%) as a model of neuronal membranes
[56]. We first analyzed the fluorescence anisotropy
ratio (r) of 1,6-diphenyl-1,3,5-hexatriene (DPH),
whose value correlates inversely to the degree of
membrane fluidity [44]. A progressive reduction of
membrane fluidity was observed in vesicles with
increasing percentage of GM1 following treatment
with either amyloid oligomer (Fig. 1C), indicating
that A– oligomers are able to penetrate and to stiffen
GM1-rich SUVs similarly to A+ oligomers in this
model system. Accordingly, the ability of both types
of oligomers to cause membrane disruption, as mea-
sured by calcein release assay, raises significantly by
increasing GM1 abundance in SUVs (Fig. 1D).
Then, we investigated the alteration of mem-
brane permeability induced by A+, A– and ADDLs
oligomers in normal and GM1-enriched neurob-
lastoma cells pre-loaded with calcein-AM as a
fluorescent probe. In agreement with the results
obtained with SUVs, A+ oligomers and ADDLs
triggered membrane permeabilization both in basal
and in GM1-enriched cells, whereas A– oligomers
became effective only in GM1-enriched cells
(Fig. 1E). Taken together, these findings suggest that
GM1 abundance modulates the ability of oligomer
conformers to disassemble the lipid bilayers both in
synthetic and in cell membranes.
Distinct oligomer conformers interact differently
with the neuronal membrane
The differential cytotoxicity behavior displayed by
A+ and A– oligomers seems to be related with the
way these two conformers interact with the target
cells. Accordingly, we investigated in GM1-enriched
neuronal cells whether A– oligomers were able to
compete with A+ conformers for cell-binding sites by
using fluorescently labelled A+ oligomers (A+FAM).
Human neuroblastoma cells were incubated with
A+FAM oligomers in the presence or absence of a
10-fold molar excess of unlabeled A– or A+
oligomers for 3 h at 4◦C, a length of time suffi-
cient to reach steady state [57]. A high degree of
co-localization of A+FAM oligomers (green channel)
with cell membranes (red channel) was observed in
the absence of energy-dependent processes (Fig. 1F).
In addition, the amount of A+FAM associated with
the cells was measured by fluorescence intensity
analysis and the data were normalized for total
protein content in the cell lysates. Unlabeled A+
oligomers induced a marked displacement of about
50% of A+FAM associated with the cells, whereas
A– oligomers induced only a displacement of about
15% (Fig. 1F). These data suggest that A+ and A–
oligomers interact with the cells at different sites
and/or with different affinities.
Different oligomer conformers induce Ca2+
dyshomeostasis by distinct molecular
mechanisms
Many studies have reported that the Ca2+ influx
from the extracellular medium into the cytosol is an
early event in the cascade of biochemical alterations
underlying A cytotoxicity [23, 58]. Therefore,
we investigated the biochemical effects of A42
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Fig. 2. Ca2+ dyshomeostasis caused by different A42 oligomer conformers on human neuroblastoma SH-SY5Y cells and rat hippocampal
primary neurons. A) Representative confocal scanning microscopy images of basal and GM1-enriched (GM1) SH-SY5Y cells showing
the levels of intracellular free Ca2+ following exposure for 60 min to A+, A–, and ADDLs oligomers (12M, monomer equivalents), or
following a pre-treatment for 60 min with A– oligomers (12M, monomer equivalents) prior to the A+ exposure. B, C) Representative
confocal scanning microscopy images of basal and GM1-enriched (GM1) SH-SY5Y cells differentiated with all-trans retinoic acid (B) and
GM1-enriched (GM1) primary rat hippocampal neurons (C) showing levels of intracellular free Ca2+ following exposure for 60 min to A+
and A– oligomers (12M, monomer equivalents), in the absence or in the presence of a pre-treatment for 20 min with the cholera toxin
subunit B (CTX-B) prior to the oligomers exposure. D) Representative confocal scanning microscopy images of basal and GM1-enriched
(GM1) SH-SY5Y cells showing levels of intracellular free Ca2+, following 10 min incubation with 0.05% trypsin prior to exposure for 10
or 60 min to A+ and A– oligomers (12M, monomer equivalents). The green fluorescence arise from Ca2+ binding to the intracellular
Fluo3 probe.
binding to GM1-enriched cells measuring the levels
of intracellular Ca2+ by confocal microscopy using
Fluo3-AM as a probe. We found that A+ oligomers
and ADDLs caused an extensive influx of Ca2+ ions
into neuronal cells with either basal or enriched
content of GM1, whereas A– oligomers became
effective only in GM1-enriched cells (Fig. 2A). More-
over, pre-treating cells with basal GM1 content with
A– oligomers did not prevent Ca2+ influx induced
by A+ oligomers (Fig. 2A). The different effects
of the two oligomer conformers were confirmed in
neuroblastoma cells differentiated with retinoic acid
for six days (Fig. 2B). Finally, we found that Ca2+
dyshomeostasis induced by soluble oligomers was
completely rescued by cell treatment with the spe-
cific GM1-ligand cholera toxin -subunit (CTX-B),
a component of the enterotoxin produced by
Vibrio cholerae (Fig. 2B). This evidence was con-
firmed in primary hippocampal neurons from rat
brain (Fig. 2C), a more relevant model for AD stud-
ies. Taken together, these data suggest that A+ and A–
oligomers induce Ca2+ dyshomeostasis by distinct,
yet GM1-dependent, molecular mechanisms.
To further define the early phase of oligomer-
membrane interaction, we incubated neuroblastoma
cells with A+ and A– oligomers for 10 min at 4◦C.
In agreement with the results reported above, A+
oligomers, but not A– oligomers, induced an exten-
sive influx of Ca2+ ions into neuronal cells with
basal GM1 content (Fig. 2D). We also removed the
proteins exposed on the cell membrane by incubat-
ing the cells with 0.05% trypsin. Confocal image of
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GM1-enriched cells showed that trypsin treatment
prevented the early (10 min), but not the delayed
(60 min) Ca2+ influx induced by A+ oligomers
(Fig. 2D) as compared to control samples (Fig. 2A).
On the contrary, trypsin treatment did not affect the
interaction of A– oligomers with the GM1-enriched
cells neither at early nor at longer incubation times
(compare Fig. 2D with Fig. 2A). These data indicate
that the mechanism by which A+ and A– interact with
the cells is different; they also suggest that a specific
membrane protein(s) might be involved in the early
interaction of the A+ oligomers but not A– oligomers
with the cells.
A11-positive oligomers co-localize with
glutamatergic receptors
It has been reported that misfolded protein
oligomers trigger Ca2+ influx by both channel-
independent and channel-dependent alteration of the
selective permeability of lipid bilayers [25, 59, 60].
Voltage-gated [61] or ligand-gated calcium chan-
nels, such as the glutamate NMDA-R and AMPA-R
[35, 62], have been considered as possible recep-
tors or specific interaction sites for oligomers. To
gain deeper insight on A+ and A– oligomer bind-
ing to AMPA-R and NMDA-R embedded into the
Fig. 3. Co-localization of A+ and A– A42 oligomers with NMDA-R and AMPA-R in human neuroblastoma SH-SY5Y cells and primary
hippocampal neurons. A, B) Representative confocal scanning microscopy images of primary rat hippocampal neurons treated for 20 min with
A+ and A– oligomers (12M, monomer equivalents). C) Representative confocal scanning microscopy images of basal and GM1-enriched
(GM1) SH-SY5Y cells treated for 20 min with A+ and A– oligomers (12M, monomer equivalents). D) Representative confocal scanning
microscopy images showing basal and GM1-enriched (GM1) SH-SY5Y cells treated for 20 min with A+ oligomers (12M, monomer
equivalents). Red and green fluorescences indicate the NMDA-R or AMPA-R and the A42 oligomers, respectively. The histograms show
the percentage of co-localization on regions of interest (12–13 cells) using the ImageJ (NIH, Bethesda, MD, USA) and JACOP plugin
(rsb.info.nih.gov) software. Data are expressed as mean ± SD (n= 18 per group). E) Examples of FRET efficiency images, reflecting the
molecular interaction of A+ oligomers with AMPA-R and NMDA-R in human neuronal cells. Fluorescence intensities of Alexa Fluor 488
associated with oligomers are displayed in pseudo color according to the bar scale, with red pixels indicating intense fluorescence and blue
pixels indicating weak fluorescence. The histogram shows the FRET efficiency on regions of interest (12–13 cells) using the ImageJ (NIH,
Bethesda, MD, USA) and JACOP plugin (rsb.info.nih.gov) software. Data are expressed as mean ± SD (n= 18 per group).
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plasma membrane, we investigated whether these
assemblies were able to physically interact with the
receptors in primary rat hippocampal neurons, par-
ticularly rich in these receptors. Our results showed
a higher degree of co-localization (ca. 80%) of A+
oligomers with NMDA-R and AMPA-R both in rat
hippocampal neurons (Fig. 3A, B) and in human neu-
ronal cells (Fig. 3C, D). In contrast, a low degree of
co-localization (ca. 20%) of A– oligomers with glu-
tamatergic receptors was found in rat hippocampal
neurons (Fig. 3A, B).
To further define the A+/AMPA-R and A+/
NMDA-R spatial relations, we used FRET-
fluorescence imaging microscopy to determine
the intermolecular proximity of A+ oligomers to
glutamatergic channels at the cell surface of human
neuronal cells. The results showed a weak FRET
efficiency amounting to ca. 10% (Fig. 3E), taking
into account some concerns regarding the use of
double antibody staining, which reduces fluorophore
proximity. This evidence suggests that A+ oligomers
proximity to both AMPA-R and NMDA-R is unlikely
to involve a molecular interaction or binding. These
data also indicate that a channel-dependent mecha-
nism mediates Ca2+ dysfunction in neuronal cells
facing A+ oligomers.
Glutamatergic receptors mediate early Ca2+
dyshomeostasis induced by A11-positive
oligomers
Finally, we investigated whether GM1 density
affected the ability of A42 oligomers to influence
the channel activity of glutamatergic receptors by
a pharmacological approach. GM1-enriched neu-
ronal cells were pre-incubated for 60 min with
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), or
with memantine (mem), which are inhibitors of
AMPA-R and NMDA-R, respectively, and then
exposed to A+ or A– oligomers. CNQX and mem pre-
vented the intracellular Ca2+ influx in GM1-enriched
cells exposed for 10 min to A+ oligomers, suggest-
ing the involvement of both AMPA-R and NMDA-R
in the early stages of neuronal Ca2+ dysregulation
(Fig. 4A). In contrast, the ability of A– oligomers to
induce Ca2+ influx in GM1-enriched cells was not
affected by any pharmacological treatment (Fig. 4B),
indicating that A– cytotoxicity was not mediated
by calcium channels. Similar results were obtained
in cells treated with anti-AMPA or anti-NMDA
antibodies (Fig. 4A, B), whereas Cd2+ could not
rescue the Ca2+ dyshomeostasis induced by either
Fig. 4. Effects of antagonists on the Ca2+ influx induced after 10
min of treatment with A42 oligomers in GM1-enriched cells. A,
B) Representative confocal scanning microscopy images of GM1-
enriched SH-SY5Y cells showing levels of intracellular free Ca2+
following exposure for 10 min to A+ (A) and A– (B) oligomers
(12M, monomer equivalents) in the presence of 5M CNQX,
10M mem, 10M Cd2+, 1:200 anti-AMPA-R or 1:200 anti-
NMDA-R antibodies. The green fluorescence arise from Ca2+
binding to the intracellular Fluo3 probe.
oligomer (Fig. 4A, B), suggesting that VDCCs are not
involved.
To confirm and extend the validity of the results
reported above, we also investigated, in the same
way, the behavior of two different types of oligomers,
type A and type B, with different cytotoxicities grown
from the model protein HypF-N (Fig. 5A, B). First,
we confirmed that type A oligomers of HypF-N
compete with A+ conformers of A42 for neuronal-
binding sites by using labelled A+FAM oligomers.
Indeed, a 10-fold molar excess of unlabeled type A
oligomers of HypF-N induced a marked displace-
ment of about 40% of A+FAM associated with human
neuroblastoma cells (Fig. 5C). We also found that
Ca2+ dyshomeostasis triggered by both types of
HypF-N oligomers in basal or GM1-enriched cells
was very similar to that induced by A42 oligomers
(Fig. 5D-F). Indeed, similarly to A– oligomers, type
AU
TH
OR
 C
OP
Y
R. Cascella et al. / High-Density GM1 as a Player in AD Pathogenesis 933
B oligomers did not block the neuronal response to
toxic A+ oligomers (Fig. 5D). In addition, CNQX and
mem, similarly to anti-AMPA-R and anti-NMDA-
R antibodies, were able to selectively inhibit Ca2+
influx induced by type A, but not type B, oligomers in
GM1-enriched cells (Fig. 5E, F), whereas, Cd2+ did
not modify Ca2+ influx induced by either oligomer
(Fig. 5E, F). The similarity of the effects induced in
cells exposed to A and HypF-N oligomers suggests
that these effects arise from a common behavior that
is largely independent of the sequence of the protein
involved.
Finally, we carried out a time-course analysis of
the Ca2+ dyshomeostasis assessed in GM1-enriched
cells exposed to type A or type B oligomers of HypF-
N for different lengths of time (Fig. 6). CNQX or
mem did not inhibit calcium influx in neuronal cell
exposed to type A oligomers for longer lengths of
time (15–180 min) (Fig. 6A), suggesting that AMPA-
R and NMDA-R are involved only in the early stages
of Ca2+ dyshomeostasis, while thereafter a channel-
independent mechanism did occur. To better assess
this point, we plotted the normalized Ca2+ fluores-
cence, quantified as the percentage of the maximum
value measured in cells exposed to the ionophore
ionomycin, as a function of time (Fig. 6C). Inter-
estingly, a lag phase in the fluorescence spike was
observed in the presence of CNQX and mem in cells
exposed to type A oligomers (Fig. 6C). By con-
trast, no effects of CNQX or mem were observed
on cells exposed to type B oligomers (Fig. 6B, D),
excluding the involvement of calcium channels in
cellular dyshomeostasis triggered by this conformer.
These findings suggest that the interference of protein
misfolded oligomers with a large solvent-exposed
Fig. 5. A) Dot-blot analysis of type A and type B oligomers
of HypF-N probed with conformation-specific (A11, prefibril-
lar oligomers, top) and sequence-specific anti-HypF-N antibodies
(bottom). B) MTT reduction of basal and GM1-enriched (GM1)
SH-SY5Y cells treated for 24 h with type A and type B oligomers
of HypF-N (12M, monomer equivalents). Data are expressed
as mean ± SD (n= 4 per group). The triple (***) asterisk refers
to p values lower than 0.001 relative to untreated cells. C) The
histogram shows the fluorescence intensity of A+FAM oligomers
(1M, monomer equivalents) associated with cells following incu-
bation in the absence or in the presence of 10 × molar excess of
unlabeled HypF-N type A oligomers (10M, monomer equiva-
lents) for 3 h at 4◦C. The fluorescence associated with the cells was
normalized by total protein content. The triple (***) asterisk refers
to p values lower than 0.001 relative to cells treated with A+FAM
only. D) Representative confocal scanning microscopy images of
basal SH-SY5Y cells showing levels of intracellular free Ca2+ fol-
lowing exposure for 60 min to type A and type B oligomers (12M,
monomer equivalents), or to 1M ionomycin, or following a pre-
treatment with type B oligomers (12M, monomer equivalents)
prior to the A+ oligomers exposure. E, F) Representative confo-
cal scanning microscopy images of GM1-enriched SH-SY5Y cells
showing levels of intracellular free Ca2+ following exposure for
10 min to type A (E) and type B (F) oligomers (12M, monomer
equivalents) in the presence of 5M CNQX, 10M mem, 10M
Cd2+, 1:200 anti-AMPA or 1:200 anti-NMDA antibodies. The
green fluorescence arise from Ca2+ binding to the intracellular
Fluo3 probe.
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Fig. 6. Time-course analysis of the Ca2+ influx induced by HypF-N type A and type B oligomers in GM1-enriched cells in the presence
of calcium channel antagonists. A, B) Representative confocal scanning microscopy images of GM1-enriched SH-SY5Y cells treated for
different lengths of time (0, 5, 10, 12, 15, 30, 60, and 180 min) with 12M (monomer concentration) type A (A) and type B (B) oligomers
of HypF-N, in the presence of 5M CNQX or 10M mem, showing levels of intracellular free Ca2+. In all images, the green fluorescence
arises from Ca2+ binding to the intracellular Fluo3-AM probe. C, D) Plots showing the fluorescence associated with intracellular Ca2+
versus time after treatment of the GM1-enriched cells with HypF-N type A (C) or type B (D) oligomers at 12M in the absence (black line)
or in the presence of 5M CNQX (red line), 10M mem (blue line), or 10M Cd2+ (green line).
hydrophobicity on calcium fluxes across the cell
membrane occurs in two steps: a first rapid step,
where Ca2+ influx increases due to glutamatergic
receptor stimulation, followed by a delayed step,
where a channel-independent mechanism, possibly
resulting from bilayer disassembly, is involved.
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DISCUSSION
Small soluble oligomers of A peptides, widely
reported as the most toxic form of aggregated A
species, potently disrupt cellular Ca2+ homeosta-
sis [51]. The multiplicity of A oligomeric species
is the result of inherent sequence variations, but
also of different growth conditions and experimen-
tal approaches to generate such species in vitro or
to isolate them from brain tissue [13]. Thus, we won-
dered which of these oligomeric species had the most
membrane-permeabilizing ability. Charlie Glabe and
colleagues proposed a useful approach to classify dif-
ferent conformers of A aggregates and their toxicity
based on the use of conformation-dependent antibod-
ies [53]. These recognize generic epitopes associated
with distinct peptide aggregation states rather than
specific amino acid sequences [23]. This approach
has defined the theoretical basis to investigate the
presence of different conformers of a number of pep-
tides and proteins populated over a given aggregation
pathway or a given aggregation time.
Two types of small soluble A42 oligomers have
been recently described [41]. The two oligomers
share similar sizes and a substantially unfolded sec-
ondary structure, but interact differently with the
A11 antibodies and display distinct toxic properties,
as a consequence of their structural differences, in
particular their different levels of solvent-exposed
hydrophobicity [41, 52]. Our findings show that the
different toxicities of the two types of oligomers are
strictly dependent on the GM1 content in the neuronal
membranes they interact with. In fact, the conform-
ers of A42 with low solvent-exposed hydrophobicity
(A–) increase their ability to disrupt the lipid bilay-
ers reaching a toxic efficiency comparable to that of
the high solvent-exposed hydrophobic species (A+)
when the plasma membrane of the cells contains
increased GM1 density. In addition, we show that
GM1 modulates the affinity of A42 oligomers to
synthetic or natural cell membranes, as well as the
ability of the oligomers to affect membrane lipid
order and permeability, regardless of the oligomer
type. This conclusion is confirmed and made more
general by the substantially similar results obtained
with two comparable types of HypF-N oligomers,
suggesting a general mechanism independent of the
protein sequence. These results indicate that all pro-
tein misfolded oligomers have a significant level of
toxicity in appropriate environments; an ensemble of
different oligomeric species can be present in tissue,
each capable to damage neuronal cells with different
efficiency depending on its biophysical features and
GM1 abundance in the cell membrane. This is partic-
ularly relevant, considering that in this study we used
an increased GM1 content comparable to that found
in the neuronal membrane of aged people and of AD
patients [2, 3, 37].
The affinity of protein aggregates for membrane
GM1 was suggested to involve the negative charge
of the sialic acid [63, 64]. Our results agree with
these considerations; in fact, we showed that A42
oligomers display an increased tendency to inter-
act with SUVs as far as GM1 abundance is raised,
supporting the idea that aggregate binding is not
only driven by the presence of membrane protein
targets [64]. The increase in GM1 content appears
to affect clustering and enlargement of existing raft
platforms, or to induce the formation of new ones
[2]. This view agrees with our recent data showing
a reduced mobility of GM1 molecules in GM1-
enriched neuronal cells by Single Molecule Tracking
(SMT) experiments [8]. Our data also agree with sev-
eral reports indicating that the cholesterol content
affects membrane physical features such as fluid-
ity and GM1 clustering, hindering both aggregate
recruitment at the cell membrane and membrane per-
meabilization [63, 65]. Overall, our results indicate
that age-dependent clustering of membrane GM1 in
neurons, a well-known alteration in the AD brain [3],
can represent a risk for neurodegeneration in elderly
people as a consequence of an increased ability of the
lipid components of the bilayers to recruit membrane-
permeabilizing oligomers without any involvement
of specific receptors.
The molecular mechanism responsible for neu-
ronal alterations induced by A oligomers has also
been associated with direct or indirect interactions
with specific receptors and activation of specific
signaling pathways [32, 66] and intra/extracellular
perturbation of cell membranes [23]. A oligomers
have also been shown to interfere with NMDA-R
and postsynaptic AMPA-R, affecting synaptic func-
tion, calcium influx, and a number of downstream
cascades [13]. The idea that cell death in AD is
associated with over-activity of NMDA-R provides
part of the basis for the use of the low affinity activity-
dependent NMDA-R antagonist, memantine, to treat
this pathology [67]. In the present study, we show
that both AMPA-R and NMDA-R, but not voltage-
gated calcium channels, are involved in the early
disruption of Ca2+ homeostasis induced by toxic A
oligomers (A+). In fact, the pharmacological inhi-
bition of glutamatergic receptors transiently delayed
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Ca2+ influx induced by A11-positive toxic oligomers
grown from two completely unrelated polypeptide
chains such as A42 and HypF-N. In addition,
we show that A11-positive oligomers accumulate
in proximity of glutamatergic channels more effi-
ciently than their A11-negative conformers; however,
a close proximity to AMPA-R and NMDA-R cannot
be confirmed in our experimental conditions. This
finding suggests that oligomers with high solvent-
exposed hydrophobicity (A+ or type A for A42 or
HypF-N, respectively), unlike low solvent-exposed
hydrophobic conformers (A− or type B for A42
or HypF-N, respectively), promptly stimulate gluta-
matergic calcium channels without a close molecular
interaction. A rapid decrease of NMDA-R responses
could explain a minor involvement of these endoge-
nous protein-channels at a later stage of cell exposure
to the oligomers, considering that A application to
neurons has been reported to induce receptor endo-
cytosis with loss of synaptic receptor [31].
In conclusion, our results indicate that cytotoxi-
city of protein misfolded oligomers is related to a
more general mechanism involving the destabiliza-
tion and disassembly of the lipid membrane within
GM1-rich raft regions, causing an influx of Ca2+ ions
from the extracellular to the intracellular environ-
ment, involving both protein and lipid components
as far as the time of cell exposure to the oligomers is
increased. This finding could explain why treatment
of AD patients with memantine has resulted in mixed
success in treating memory impairments and the pro-
gression of neurodegeneration [68]; it also sheds new
light on the molecular determinants of protein mis-
folding and protein deposition diseases and expands
the spectrum of molecular targets for therapeutic
interventions against protein deposition diseases. Our
findings support a main role for GM1 ganglioside in
mediating the interaction of lipid bilayers with A42
oligomers and support a mechanism of oligomer cyto-
toxicity involving bilayer destabilization by soluble
oligomers within GM1-rich ordered raft regions. This
evidence suggests that the cytotoxic effect of protein
misfolded oligomers may not be exclusively related
to a single mechanism of Ca2+ influx, but more likely
to a collection of mechanisms involving membrane
protein channels and lipid components.
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